Article Details

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Average Recommendation of “Buy ...

Retrieved on: 2022-06-10 10:47:04

Tags for this article:

Click the tags to see associated articles and topics

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Average Recommendation of “Buy .... View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 2,433,595 shares of the biopharmaceutical company's stock worth $82,889,000 after buying an additional 20,539 shares in ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up